Pulmonologist Perspectives: The Use of Immune Checkpoint Inhibitors in Practice

Access Course

 

4a9408df-ed81-42bf-8167-018443e9f780.jpgLearn how treatment of NSCLC with checkpoint inhibitors will affect your clinical outlook.


This activity is intended for pulmonologists, ID/HIV specialists, and pathologists who treat patients with lung cancer.

The goal of this activity is to provide pulmonologists perspectives on how immune checkpoint inhibitors may alter the diagnostic algorithm in individuals with suspected lung cancer. 

 

 

Approximate Time to Complete: 20 minutes

 

Course Available Beginning: Aug. 31, 2016

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Interpret clinical evidence related to the use of immune checkpoint inhibitors in patients with lung cancer
  • Identify how the incorporation of immune checkpoint inhibitors in patients with lung cancer may alter diagnostic strategies